{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:12:21Z","timestamp":1793211141943,"version":"4.5.0"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100007197","name":"USPHS","doi-asserted-by":"publisher","award":["RO1MH092412"],"award-info":[{"award-number":["RO1MH092412"]}],"id":[{"id":"10.13039\/100007197","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007197","name":"USPHS","doi-asserted-by":"publisher","award":["R01DA033646"],"award-info":[{"award-number":["R01DA033646"]}],"id":[{"id":"10.13039\/100007197","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.neuropharm.2017.02.005","type":"journal-article","created":{"date-parts":[[2017,2,7]],"date-time":"2017-02-07T19:01:05Z","timestamp":1486494065000},"page":"401-407","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"special_numbering":"C","title":["Genetic variation in the behavioral effects of buprenorphine in female mice derived from a murine model of the OPRM1 A118G polymorphism"],"prefix":"10.1016","volume":"117","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7463-7870","authenticated-orcid":false,"given":"Caroline A.","family":"Browne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca L.","family":"Erickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Blendy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irwin","family":"Lucki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2017.02.005_bib1","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1177\/0269881115586937","article-title":"Combined administration of buprenorphine and naltrexone produces antidepressant-like effects in mice","volume":"29","author":"Almatroudi","year":"2015","journal-title":"J.\u00a0Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2017.02.005_bib2","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2217\/pgs.15.157","article-title":"The pharmacogenetics of opioid therapy in the management of postpartum pain: a systematic review","volume":"17","author":"Baber","year":"2016","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.neuropharm.2017.02.005_bib3","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1016\/j.euroneuro.2015.04.013","article-title":"Increased mesolimbic cue-reactivity in carriers of the mu-opioid-receptor gene OPRM1 A118G polymorphism predicts drinking outcome: a functional imaging study in alcohol dependent subjects","volume":"25","author":"Bach","year":"2015","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2017.02.005_bib4","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1038\/npp.2008.234","article-title":"Enhanced sensitivity of the MRL\/MpJ mouse to the neuroplastic and behavioral effects of chronic antidepressant treatments","volume":"34","author":"Balu","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2017.02.005_bib5","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/sj.mp.4000331","article-title":"Mu opioid receptor gene variants: lack of association with alcohol dependence","volume":"2","author":"Bergen","year":"1997","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2017.02.005_bib6","doi-asserted-by":"crossref","first-page":"9608","DOI":"10.1073\/pnas.95.16.9608","article-title":"Single-nucleotide polymorphism in the human mu opioid receptor gene alters beta-endorphin binding and activity: possible implications for opiate addiction","volume":"95","author":"Bond","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2017.02.005_bib7","doi-asserted-by":"crossref","first-page":"2517","DOI":"10.1007\/s00221-015-4322-9","article-title":"Polymorphism in the micro-opioid receptor gene (OPRM1) modulates neural processing of physical pain, social rejection and error processing","volume":"233","author":"Bonenberger","year":"2015","journal-title":"Exp. Brain Res."},{"key":"10.1016\/j.neuropharm.2017.02.005_bib8","first-page":"E227","article-title":"The role of hydromorphone and OPRM1 in postoperative pain relief with hydrocodone","volume":"16","author":"Boswell","year":"2013","journal-title":"Pain Physician"},{"key":"10.1016\/j.neuropharm.2017.02.005_bib58","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1523\/JNEUROSCI.4685-14.2015","article-title":"Mouse model of OPRM1 (A118G) polymorphism increases sociability and dominance and confers resilience to social defeat","volume":"35","author":"Briand","year":"2015","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2017.02.005_bib59","doi-asserted-by":"crossref","first-page":"E467","DOI":"10.1002\/oby.20202","article-title":"Association of dopamine D2 receptor and leptin receptor genes with clinically severe obesity","volume":"21","author":"Carpenter","year":"2013","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.neuropharm.2017.02.005_bib9","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1038\/npp.2009.183","article-title":"Antidepressant-like effects of kappa-opioid receptor antagonists in Wistar Kyoto rats","volume":"35","author":"Carr","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2017.02.005_bib10","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1007\/s00213-010-1832-9","article-title":"Comparison of the kappa-opioid receptor antagonist DIPPA in tests of anxiety-like behavior between Wistar Kyoto and Sprague Dawley rats","volume":"210","author":"Carr","year":"2010","journal-title":"Psychopharmacol. Berl."},{"key":"10.1016\/j.neuropharm.2017.02.005_bib11","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1097\/00000542-200608000-00016","article-title":"Human opioid receptor A118G polymorphism affects intravenous patient-controlled analgesia morphine consumption after total abdominal hysterectomy","volume":"105","author":"Chou","year":"2006","journal-title":"Anesthesiology"},{"key":"10.1016\/j.neuropharm.2017.02.005_bib12","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1111\/j.1399-6576.2006.01058.x","article-title":"Association of mu-opioid receptor gene polymorphism (A118G) with variations in morphine consumption for analgesia after total knee arthroplasty","volume":"50","author":"Chou","year":"2006","journal-title":"Acta Anaesthesiol. Scand."},{"key":"10.1016\/j.neuropharm.2017.02.005_bib13","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/adb.12013","article-title":"Fronto-striatal functional connectivity during response inhibition in alcohol dependence","volume":"18","author":"Courtney","year":"2013","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neuropharm.2017.02.005_bib14","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1476-5381.1977.tb07532.x","article-title":"Agonist and antagonist properties of buprenorphine, a new antinociceptive agent","volume":"60","author":"Cowan","year":"1977","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.02.005_bib15","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s002130050327","article-title":"Behavioral phenotypes of inbred mouse strains: implications and recommendations for molecular studies","volume":"132","author":"Crawley","year":"1997","journal-title":"Psychopharmacol. Berl."},{"key":"10.1016\/j.neuropharm.2017.02.005_bib16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.pbb.2013.10.018","article-title":"Pharmacogenetics of OPRM1","volume":"123","author":"Crist","year":"2014","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2017.02.005_bib17","doi-asserted-by":"crossref","first-page":"1704","DOI":"10.1111\/j.1476-5381.2011.01482.x","article-title":"Mechanisms of rapid opioid receptor desensitization, resensitization and tolerance in brain neurons","volume":"165","author":"Dang","year":"2012","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.02.005_bib60","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1038\/oby.2009.52","article-title":"Dopamine for \u201cwanting\u201d and opioids for \u201cliking\u201d: a comparison of obese adults with and without binge eating","volume":"17","author":"Davis","year":"2009","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.neuropharm.2017.02.005_bib18","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.neubiorev.2005.03.017","article-title":"Recent advances in animal models of chronic antidepressant effects: the novelty-induced hypophagia test","volume":"29","author":"Dulawa","year":"2005","journal-title":"Neurosci. Biobehav Rev."},{"key":"10.1016\/j.neuropharm.2017.02.005_bib61","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0006-8993(01)03094-3","article-title":"Excitatory amino acid receptor subtype agonists induce feeding in the nucleus accumbens shell in rats: opioid antagonist actions and interactions with mu-opioid agonists","volume":"921","author":"Echo","year":"2001","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2017.02.005_bib62","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1038\/npp.2014.330","article-title":"Evaluation of opioid modulation in major depressive disorder","volume":"40","author":"Ehrich","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2017.02.005_bib19","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1038\/npp.2016.38","article-title":"Antidepressant-like effects of buprenorphine are mediated by kappa opioid receptors","volume":"41","author":"Falcon","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2017.02.005_bib20","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s00213-014-3723-y","article-title":"Effects of buprenorphine on behavioral tests for antidepressant and anxiolytic drugs in mice","volume":"232","author":"Falcon","year":"2015","journal-title":"Psychopharmacol. Berl."},{"key":"10.1016\/j.neuropharm.2017.02.005_bib21","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/sj.mp.4000556","article-title":"Genetics of two mu opioid receptor gene (OPRM1) exon I polymorphisms: population studies, and allele frequencies in alcohol- and drug-dependent subjects","volume":"4","author":"Gelernter","year":"1999","journal-title":"Mol. Psychiatry"},{"issue":"Suppl.\u00a01","key":"10.1016\/j.neuropharm.2017.02.005_bib22","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.pain.2007.10.014","article-title":"Studying sex and gender differences in pain and analgesia: a consensus report","volume":"132","author":"Greenspan","year":"2007","journal-title":"Pain"},{"key":"10.1016\/j.neuropharm.2017.02.005_bib23","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1002\/syn.21914","article-title":"Mediation of buprenorphine analgesia by a combination of traditional and truncated mu opioid receptor splice variants","volume":"70","author":"Grinnell","year":"2016","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2017.02.005_bib24","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.molbrainres.2003.10.024","article-title":"mu-Opioid receptor knockout mice display reduced cocaine conditioned place preference but enhanced sensitization of cocaine-induced locomotion","volume":"121","author":"Hall","year":"2004","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.neuropharm.2017.02.005_bib25","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/1471-2474-15-161","article-title":"Subjective health complaints in patients with lumbar radicular pain and disc herniation are associated with a sex - OPRM1 A118G polymorphism interaction: a prospective 1-year observational study","volume":"15","author":"Hasvik","year":"2014","journal-title":"BMC Musculoskelet. Disord."},{"key":"10.1016\/j.neuropharm.2017.02.005_bib26","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1042\/BJ20111050","article-title":"A\u00a0common single nucleotide polymorphism A118G of the mu opioid receptor alters its N-glycosylation and protein stability","volume":"441","author":"Huang","year":"2012","journal-title":"Biochem. J."},{"key":"10.1016\/j.neuropharm.2017.02.005_bib27","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1038\/sj.npp.1300463","article-title":"Buprenorphine antinociception is abolished, but naloxone-sensitive reward is retained, in mu-opioid receptor knockout mice","volume":"29","author":"Ide","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2017.02.005_bib28","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.biopsych.2007.05.001","article-title":"Mood and neuroendocrine response to a chemical stressor, metyrapone, in buprenorphine-maintained heroin dependence","volume":"63","author":"Kakko","year":"2008","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2017.02.005_bib29","doi-asserted-by":"crossref","first-page":"e785","DOI":"10.4088\/JCP.13m08725","article-title":"Safety, tolerability, and clinical effect of low-dose buprenorphine for treatment-resistant depression in midlife and older adults","volume":"75","author":"Karp","year":"2014","journal-title":"J.\u00a0Clin. Psychiatry"},{"key":"10.1016\/j.neuropharm.2017.02.005_bib30","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ejphar.2007.08.026","article-title":"Pharmacological evidence for the involvement of the opioid system in the antidepressant-like effect of adenosine in the mouse forced swimming test","volume":"576","author":"Kaster","year":"2007","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.02.005_bib31","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/bph.12644","article-title":"Cellular signalling of non-synonymous single-nucleotide polymorphisms of the human mu-opioid receptor (OPRM1)","volume":"172","author":"Knapman","year":"2015","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.02.005_bib32","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1111\/bph.12785","article-title":"Buprenorphine signalling is compromised at the N40D polymorphism of the human mu opioid receptor in\u00a0vitro","volume":"171","author":"Knapman","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2017.02.005_bib33","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1590\/S1415-4757382220140299","article-title":"Human population genetic structure detected by pain-related mu opioid receptor gene polymorphisms","volume":"38","author":"Lopez Soto","year":"2015","journal-title":"Genet. Mol. Biol."},{"key":"10.1016\/j.neuropharm.2017.02.005_bib34","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1038\/npp.2015.101","article-title":"Cortisol stress response in men and women modulated differentially by the mu-opioid receptor gene polymorphism OPRM1 A118G","volume":"40","author":"Lovallo","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2017.02.005_bib35","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s002130100694","article-title":"Sensitivity to the effects of pharmacologically selective antidepressants in different strains of mice","volume":"155","author":"Lucki","year":"2001","journal-title":"Psychopharmacol. Berl."},{"key":"10.1016\/j.neuropharm.2017.02.005_bib36","doi-asserted-by":"crossref","first-page":"10331","DOI":"10.1523\/JNEUROSCI.23-32-10331.2003","article-title":"Buprenorphine-induced antinociception is mediated by mu-opioid receptors and compromised by concomitant activation of opioid receptor-like receptors","volume":"23","author":"Lutfy","year":"2003","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.02.005_bib37","doi-asserted-by":"crossref","first-page":"10847","DOI":"10.1073\/pnas.0901800106","article-title":"Mouse model of OPRM1 (A118G) polymorphism has sex-specific effects on drug-mediated behavior","volume":"106","author":"Mague","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2017.02.005_bib38","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1124\/jpet.102.046433","article-title":"Antidepressant-like effects of kappa-opioid receptor antagonists in the forced swim test in rats","volume":"305","author":"Mague","year":"2003","journal-title":"J.\u00a0Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuropharm.2017.02.005_bib39","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1097\/ALN.0b013e318231fc11","article-title":"Pharmacological consequence of the A118G mu opioid receptor polymorphism on morphine- and fentanyl-mediated modulation of Ca(2) (+) channels in humanized mouse sensory neurons","volume":"115","author":"Mahmoud","year":"2011","journal-title":"Anesthesiology"},{"key":"10.1016\/j.neuropharm.2017.02.005_bib40","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jad.2004.09.008","article-title":"Gender differences in depression: findings from the STAR*D study","volume":"87","author":"Marcus","year":"2005","journal-title":"J.\u00a0Affect Disord."},{"key":"10.1016\/j.neuropharm.2017.02.005_bib41","doi-asserted-by":"crossref","first-page":"5674","DOI":"10.1523\/JNEUROSCI.23-13-05674.2003","article-title":"Kappa opioid receptor antagonism and prodynorphin gene disruption block stress-induced behavioral responses","volume":"23","author":"McLaughlin","year":"2003","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.02.005_bib42","doi-asserted-by":"crossref","first-page":"11608","DOI":"10.1073\/pnas.1000751107","article-title":"Ligand-directed c-Jun N-terminal kinase activation disrupts opioid receptor signaling","volume":"107","author":"Melief","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2017.02.005_bib43","doi-asserted-by":"crossref","first-page":"331","DOI":"10.2147\/JPR.S42040","article-title":"Consequences of the 118A>G polymorphism in the OPRM1 gene: translation from bench to bedside?","volume":"6","author":"Mura","year":"2013","journal-title":"J.\u00a0Pain Res."},{"key":"10.1016\/j.neuropharm.2017.02.005_bib44","doi-asserted-by":"crossref","first-page":"4751","DOI":"10.1093\/hmg\/dds314","article-title":"Genetic-epigenetic interaction modulates mu-opioid receptor regulation","volume":"21","author":"Oertel","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neuropharm.2017.02.005_bib45","doi-asserted-by":"crossref","first-page":"9831","DOI":"10.1523\/JNEUROSCI.1742-12.2012","article-title":"Pain intensity the first year after lumbar disc herniation is associated with the A118G polymorphism in the opioid receptor mu 1 gene: evidence of a sex and genotype interaction","volume":"32","author":"Olsen","year":"2012","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.neuropharm.2017.02.005_bib46","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.neuropharm.2010.08.003","article-title":"The role of beta-arrestin2 in the severity of antinociceptive tolerance and physical dependence induced by different opioid pain therapeutics","volume":"60","author":"Raehal","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2017.02.005_bib47","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1038\/mp.2010.56","article-title":"A\u00a0genetic determinant of the striatal dopamine response to alcohol in men","volume":"16","author":"Ramchandani","year":"2011","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neuropharm.2017.02.005_bib48","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00213-006-0504-2","article-title":"Association of OPRM1 A118G variant with the relative reinforcing value of nicotine","volume":"188","author":"Ray","year":"2006","journal-title":"Psychopharmacol. Berl."},{"key":"10.1016\/j.neuropharm.2017.02.005_bib49","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1007\/s11920-014-0504-6","article-title":"Genetics of opiate addiction","volume":"16","author":"Reed","year":"2014","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.neuropharm.2017.02.005_bib50","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1038\/npp.2015.109","article-title":"Receptor reserve moderates mesolimbic responses to opioids in a humanized mouse model of the OPRM1 A118G polymorphism","volume":"40","author":"Robinson","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2017.02.005_bib51","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.bbr.2016.10.050","article-title":"A\u00a0role for the mu opioid receptor in the antidepressant effects of buprenorphine","volume":"319","author":"Robinson","year":"2016","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2017.02.005_bib52","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1097\/ALN.0b013e318182af21","article-title":"A118G single nucleotide polymorphism of human mu-opioid receptor gene influences pain perception and patient-controlled intravenous morphine consumption after intrathecal morphine for postcesarean analgesia","volume":"109","author":"Sia","year":"2008","journal-title":"Anesthesiology"},{"key":"10.1016\/j.neuropharm.2017.02.005_bib53","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1089\/gtmb.2013.0282","article-title":"Effects of OPRM1 A118G polymorphism on epidural analgesia with fentanyl during labor: a meta-analysis","volume":"17","author":"Song","year":"2013","journal-title":"Genet. Test. Mol. Biomarkers"},{"key":"10.1016\/j.neuropharm.2017.02.005_bib63","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.neuroscience.2011.12.033","article-title":"Reduced expression of the mu opioid receptor in some, but not all, brain regions in mice with OPRM1 A112G","volume":"205","author":"Wang","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2017.02.005_bib54","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/j.1369-1600.2012.00484.x","article-title":"Brain region- and sex-specific alterations in DAMGO-stimulated [(35) S]GTPgammaS binding in mice with Oprm1 A112G","volume":"19","author":"Wang","year":"2014","journal-title":"Addict. Biol."},{"key":"10.1016\/j.neuropharm.2017.02.005_bib55","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s11920-006-0007-1","article-title":"Depression in children and adolescents: does gender make a difference?","volume":"8","author":"Weller","year":"2006","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.neuropharm.2017.02.005_bib57","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1038\/npp.2014.286","article-title":"Mouse model of the OPRM1 (A118G) polymorphism: differential heroin self-administration behavior compared with wild-type mice","volume":"40","author":"Zhang","year":"2015","journal-title":"Neuropsychopharmacology"},{"issue":"38","key":"10.1016\/j.neuropharm.2017.02.005_bib64","doi-asserted-by":"crossref","first-page":"32618","DOI":"10.1074\/jbc.M504942200","article-title":"Allelic expression imbalance of human mu opioid receptor (OPRM1) caused by variant A118G","volume":"280","author":"Zhang","year":"2005","journal-title":"J. Biol. Chem."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390817300461?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390817300461?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,2]],"date-time":"2020-10-02T01:17:53Z","timestamp":1601601473000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390817300461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":63,"alternative-id":["S0028390817300461"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.02.005","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic variation in the behavioral effects of buprenorphine in female mice derived from a murine model of the OPRM1 A118G polymorphism","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2017.02.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}